March 6, 2023Open Access

E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells viaModulating the miR-29c-3p/COL11A1 Signaling Axis

ZMZhifeng MaEast China University of Science and Technology TZTing ZhuFujian Medical University HWHaiyong WangBeijing Biocytogen (China)

Key Points

Key points are not available for this paper at this time.

Abstract

E2F1 affected the viability, cell cycle, and apoptosis of ESCA cells by modulating miR-29c-3p/COL11A1, and it attenuated the sensitivity of ESCA cells to sorafenib, shedding new light on the treatment of ESCA.

AI에게 질문

Bookmark

View Full Paper